FDA Warning Letter — Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
The FDA took a Warning Letter action against Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. on August 1, 2024 (Foshan, China). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
- Date
- August 1, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Foshan (China)